Illumina, Inc. vs Direxion NASDAQ 100 Equal Weighted Index Shares — how do they compare? Illumina, Inc. trades at $192.8 (market cap $27.94B), while Direxion NASDAQ 100 Equal Weighted Index Shares trades at $118.11. The key difference: Illumina, Inc. is trading nearer its 52-week high, Direxion NASDAQ 100 Equal Weighted Index Shares nearer its low. Which is the better fit depends on your goals.
| ILMN | QQQE | |
|---|---|---|
Market Cap | $27.94B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $194.33 | $122.72 |
52-Week Low | $91.00 | $96.06 |
Enterprise Value | $29.33B | — |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →QQQE is an ETF that seeks to track the performance of the NASDAQ-100 Equal Weighted Index. Unlike traditional market-capitalization-weighted indexes, this fund assigns equal weight to each of the 100 non-financial companies in the NASDAQ-100 and rebalances quarterly. This equal-weighting scheme reduces concentration risk in the largest technology companies and increases the fund's exposure to smaller-cap and mid-cap companies within the index, providing a differentiated growth profile.
Read more on QQQE →